Net Loss per Share (Details) - shares |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Antidilutive securities (in shares) | 2,564,063 | 2,634,163 | 2,564,063 | 2,634,163 |
| Outstanding stock options | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Antidilutive securities (in shares) | 1,905,404 | 2,102,627 | 1,905,404 | 2,102,627 |
| Unvested restricted stock units and performance stock units | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Antidilutive securities (in shares) | 654,792 | 515,596 | 654,792 | 515,596 |
| Potential shares issuable under the 2020 ESPP | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Antidilutive securities (in shares) | 3,867 | 15,940 | 3,867 | 15,940 |